Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- The rise of Web commuting (Citrix Online)
Preventing Osteoporosis with Ipriflavone. - Review - book review
Healthy & Natural Journal, Oct, 2000 by Vicki Elmore
By Andrea Girman, M.D., M.P.H. and Carol Poole
Are you at risk for osteoporosis? This debilitating bone disease affects an estimated 1 in 5 women over age 50. If you are not opposed to or are unsure about taking conventional hormone replacement therapy, this book is a must-read before you take any action. Ipriflavone, a soybean derivative, is being hailed as an osteoporosis breakthrough. There is compelling new evidence that ipriflavone can prevent or even reverse osteoporosis. Unlike estrogen, ipriflavone doesn't have any effect on other parts of the body. It doesn't stimulate cells in the breast or uterus nor has other undesirable side effects.
As part of The Natural Pharmacist series, Dr. Girman's book cuts through the hype and gives the consumer scientific evidence about soy therapy for osteoporosis.
Prima Health,
Division of Prima Publishing,
Roseville, Calif., 2000.
Softcover, $14.95
COPYRIGHT 2000 Measurement & Data Corporation
COPYRIGHT 2000 Gale Group